21 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
prioritizes attracting and developing highly skilled talent and invests in creating a diverse, equitable and inclusive workplace that supports employees
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
and developing highly skilled talent and invests in creating a diverse, equitable and inclusive workplace that supports employees’ flexible ways
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
P E O P L E Attract and develop highly skilled talent and invest in creating a diverse, equitable and inclusive workplace that supports our staff’s
6-K
EX-99.1
tty4b8lby
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
r45y51vqqaahkhvhgf
17 Dec 20
Current report (foreign)
6:01am
6-K
EX-99.1
kmypp6
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
424B3
hn4hl
14 Nov 19
Prospectus supplement
6:10am
F-4/A
bz9c0sz3bq j8tzm
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
x1w43 2qu3m6qr
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
4mmsvuw
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
2j6cnrip96gobaf74 h9
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.1
drnb1gc8esrj 1auoj
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
EX-10.1
emx7je445797
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B
bgcxjy1t7jfhpk1
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
EX-10.1
rv3hc hvpf9k30q
16 Nov 18
Draft registration statement (amended)
12:00am